Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$1.76 - $2.83 $8,272 - $13,301
-4,700 Reduced 5.06%
88,250 $223,000
Q3 2023

Nov 09, 2023

BUY
$1.99 - $2.45 $28,928 - $35,615
14,537 Added 18.54%
92,950 $222,000
Q2 2023

Aug 14, 2023

SELL
$2.1 - $3.36 $87,297 - $139,675
-41,570 Reduced 34.65%
78,413 $181,000
Q1 2023

May 15, 2023

BUY
$2.13 - $3.6 $124,014 - $209,602
58,223 Added 94.27%
119,983 $305,000
Q4 2022

Feb 13, 2023

BUY
$2.05 - $3.47 $2,052 - $3,473
1,001 Added 1.65%
61,760 $155,000
Q3 2022

Nov 14, 2022

SELL
$0.63 - $5.47 $6,298 - $54,689
-9,998 Reduced 14.13%
60,759 $176,000
Q2 2022

Aug 11, 2022

BUY
$4.27 - $8.26 $302,132 - $584,452
70,757 New
70,757 $320,000

Others Institutions Holding SLGC

About SomaLogic, Inc.


  • Ticker SLGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 183,452,992
  • Description
  • SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...
More about SLGC
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.